Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Looking For Options Amid India’s Recent Pullback — INDA

Published 08/21/2017, 02:24 PM
Updated 05/14/2017, 06:45 AM

We have devoted some coverage lately to Asian markets amidst the recent slide in global equities, but one country that we have not touched upon recently is India.

Like other Emerging Markets, India has regressed sharply from trading at a new 52-week high just twelve trading sessions ago to its present levels, which is a fallback of more than 4% from its highs. The largest ETF tracker in the India Equity market is the $5.2 billion iShares MSCI India (NYSE:INDA) (Expense Ratio 0.71%), which has reeled in over $580 million year-to-date via creation flows, putting this fund at more than three times the size of the next largest offering in the space, WisdomTree India Earnings (NYSE:EPI) (Expense Ratio 0.84%, $1.7 billion in AUM).

There is only one other $1 billion-plus fund in this segment, and that is iShares India 50 (NASDAQ:INDY) (Expense Ratio 0.94%, $1.1 billion in AUM). After that, there is a fairly significant drop-off across other funds in this space in terms of AUM, with several “SmallCap” India portfolios that are outperforming their larger cap competitors in some cases by more than 700-800 basis points just year-to-date.

These funds include VanEck Vectors India Small-Cap (NYSE:SCIF) (Expense Ratio 0.78%, $310 million in AUM), iShares MSCI India Small-Cap (NYSE:SMIN) (Expense Ratio 0.80%, $202 million in AUM) and the $30 million Columbia India Small Cap (NYSE:SCIN) (Expense Ratio 0.86%). Given the recent decline and bearish bias in Emerging Markets including India, it would be nice to see a “Bear” or “Levered Bear” alternative in this segment, but there is not one currently as it was closed years back.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Direxion does however offer the $106 million “Levered Bull” product Direxion Daily MSCI India Bull 3X Shares (NYSE:INDL) (Expense Ratio 1.23%), which depending on a few factors, could potentially be shorted by aggressive short-term traders looking to capitalize on additional weakness in India.

iShares MSCI India ETF

The iShares MSCI India ETF (BATS:INDA) was trading at $33.38 per share on Monday afternoon, down $0.32 (-0.95%). Year-to-date, INDA has gained 24.98%, versus a 9.60% rise in the benchmark S&P 500 index during the same period.

INDA currently has an ETF Daily News SMART Grade of A (Strong Buy), and is ranked #3 of 75 ETFs in the Asia Pacific Equities Ex-China ETFs category.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.